Q3 Earnings Forecast for BBIO Issued By Leerink Partnrs
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – Equities researchers at Leerink Partnrs issued their Q3 2025 earnings per share (EPS) estimates for shares of BridgeBio Pharma in a report issued on Monday, February 24th. Leerink Partnrs analyst M. Foroohar expects that the company will earn ($0.94) per share for the quarter. The consensus estimate […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – Equities researchers at Leerink Partnrs issued their Q3 2025 earnings per share (EPS) estimates for shares of BridgeBio Pharma in a report issued on Monday, February 24th. Leerink Partnrs analyst M. Foroohar expects that the company will earn ($0.94) per share for the quarter. The consensus estimate […]
